Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
about
Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraN-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart diseaseNatriuretic peptide system gene variants are associated with ventricular dysfunction after coronary artery bypass graftingRoutine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent eraCorrelation between brain natriuretic peptide levels and the prognosis of patients with left ventricular diastolic dysfunctionB-type natriuretic peptide is a long-term predictor of all-cause mortality, whereas high-sensitive C-reactive protein predicts recurrent short-term troponin T positive cardiac events in chest pain patients: a prognostic studyBiomarkers in acute myocardial infarction.B-type natriuretic peptide levels predict extent and severity of coronary artery disease in non-ST elevation acute coronary syndrome and normal left ventricular function.Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18.Prognostic value of brain natriuretic peptide in patients with heart failure and reserved left ventricular systolic function.B-type natriuretic peptide and high sensitive C-reactive protein predict 2-year all cause mortality in chest pain patients: a prospective observational study from Salta, ArgentinaAssociation of 25-hydroxyvitamin D deficiency with NT-pro BNP levels in patients with acute myocardial infarction: a cross-sectional analysis.Value of N-terminal pro brain natriuretic peptide in predicting prognosis and severity of coronary artery disease in acute coronary syndrome.Early diagnosis of rats with acute myocardial infarction by measurement of brain natriuretic peptide.Metabolic Syndrome is Associated With Higher Wall Motion Score and Larger Infarct Size After Acute Myocardial Infarction.B-Type Natriuretic Peptide (BNP) and Left Ventricular (LV) Function in Patients with ST-Segment Elevation Myocardial Infarction (STEMI).High incidence of elevated B-type natriuretic peptide levels and risk factors for heart failure in an unselected at-risk population (stage A): implications for heart failure screening programs.Plasma Brain Natriuretic Peptide (BNP) as an Indicator of Left Ventricular Function, Early Outcome and Mechanical Complications after Acute Myocardial Infarction.A Novel Risk Stratification Model for Patients with Non-ST Elevation Myocardial Infarction in the Korea Acute Myocardial Infarction Registry (KAMIR): Limitation of the TIMI Risk Scoring System.The utility of BNP in clinical practice.Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes.B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humansAll patients older than age 60 years should not undergo a B-type natriuretic peptide screening test.Risk stratification of acute coronary syndrome patients. A multi-marker approach.Best evidence topic report. Brain natriuretic peptide as a potential marker of acute coronary syndromes.Multimarker risk stratification approach and cardiovascular outcomes in patients with stable coronary artery disease undergoing elective percutaneous coronary intervention.B-type natriuretic peptide: a critical review.Very Long-Term Prognostic Role of Admission BNP in Non-ST Segment Elevation Acute Coronary SyndromeMultimarker strategy in acute coronary syndrome--pro-multimarker.Serum B-type natriuretic peptide levels as a marker for anthracycline-induced cardiotoxicity.Peak systolic velocity using color-coded tissue Doppler imaging, a strong and independent predictor of outcome in acute coronary syndrome patients.Acute coronary syndrome in the older adults.B-type natriuretic peptides: prognostic markers in stable coronary artery disease.Acute coronary syndromes: from the laboratory markers to the coronary vesselsA Comparison of Prognostic Value of the Levels of ProBNP and Troponin T in Patients with Acute Coronary Syndrome (ACS)Preoperative B-type natriuretic peptide is as independent predictor of ventricular dysfunction and mortality after primary coronary artery bypass grafting.Vitamin d predicts all-cause and cardiac mortality in females with suspected acute coronary syndrome: a comparison with brain natriuretic Peptide and high-sensitivity C-reactive protein.Adjustment of the GRACE score by growth differentiation factor 15 enables a more accurate appreciation of risk in non-ST-elevation acute coronary syndrome.Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care.The paradox of low BNP levels in obesity.
P2860
Q24236794-753F6872-F586-4074-A02E-3EB55D8C2A82Q24607043-6D541ECC-451B-43EB-8284-D3C963122D8FQ24644704-CE77C5A8-1979-43C7-8B20-FB08674D46DBQ26471900-1A86BDEC-EE53-4AA3-B912-4CA44044BC0FQ28601952-A2D2B458-F52F-4B70-A4A8-CB23EF46B88DQ33387034-BF4AB555-A778-49D3-B109-62C9EAE9D727Q33596823-E5E13260-E251-49CE-84C4-C044E632D49FQ33596861-13A23A33-8DE6-4506-BB0E-6FD4AAA2B127Q33691730-AB020318-295C-4C8A-A0B2-AAA5DD44059AQ33706264-206C997D-52F0-4FDE-AAB2-C03A8B958E41Q34035094-220ED492-8C74-4714-B0C7-8BEBF11CD7D8Q34101745-09504781-5F93-41F3-9431-C23816C63884Q34266208-9C3CF8C3-89B6-4913-8CD4-72E8DDBBCB4CQ34676067-57B334CC-41D9-4150-944C-C450D2FC2804Q35149077-CDD2582A-6262-4A1B-86AC-1558D27E3EE1Q35154776-7AA88BF6-F221-43A1-A340-DAB5BEE95C36Q35162689-80E437CA-D3A5-4BF7-8385-CCE82FADEF68Q35193187-ACC5F48B-27DA-440E-BAEA-3699F978E9C6Q35546171-276F1EC9-CCEB-4896-8568-B8B6DE191C0CQ35856451-187A1451-F0D1-41C2-AA15-8A5E2DCCC6ABQ35926521-7F421A23-7530-4213-A660-84072C216260Q35954229-EB670E7E-A6F4-4BD4-8548-BD7B68D3A5F6Q35987037-4E509CBC-DE4B-4D88-B4EB-FA1E9D5F43FDQ36236495-3F43997D-5FD3-494B-862B-79D1E6C21E6AQ36455027-35E1CDEF-BE7B-48A8-8C20-D94DFD498A59Q36595291-733FF7C1-8901-40C7-9B73-3D369D37FD8DQ36724549-C3A54E30-55D2-4E80-9A19-3E8FA634071DQ36738245-94E191D9-C42A-425C-9168-262B2B36811CQ36799327-E0EA19E2-820F-4A19-BDAC-C1AD6021FEF8Q36825438-4ED7664A-331F-4304-9491-B54D7A84D124Q36849309-5E0B824D-A4F0-4F4B-A1C0-A3BF9AC88CE5Q36863886-0757E2F5-142D-4AA2-9AD8-B4A741EADBF1Q37118998-FAC76137-6B7C-4E55-A573-D4BC17F77D5EQ37277926-867C948E-B1DB-49F1-96EC-8113C7033AAFQ37279802-9FDF7B9E-0FFC-4981-8ED0-FA66470BECD0Q37337440-84463786-12F1-470D-A1B9-35265739D4BEQ37375126-6AC90CF7-A889-4028-8370-A933F8DF9E11Q37463255-0EA222F8-277F-44DB-9509-6B06D2165C93Q37835560-ACE7FA7C-B694-433A-9A52-048F3E6D3726Q37869374-C86537BB-06A9-4706-B809-EEAB559C40B6
P2860
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@en
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@nl
type
label
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@en
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@nl
prefLabel
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@en
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@nl
P2093
P1476
Evaluation of B-type natriuret ...... prognosis in TACTICS-TIMI 18.
@en
P2093
C Michael Gibson
Carolyn H McCabe
Christopher P Cannon
David A Morrow
James A de Lemos
Laura A Demopoulos
Marc S Sabatine
Peter M DiBattiste
Sabina A Murphy
P304
P356
10.1016/S0735-1097(03)00168-2
P407
P577
2003-04-01T00:00:00Z